drugset / Trial / NCT05442151

Evaluation Using FAPI-PET Targeting Cancer-associated Fibroblasts

NCT05442151 ↗

Recruiting 200 enrolled Tadashi Watabe
NaSingle-groupOpen-labelDiagnostic

Summary

PET / CT examination using \[18F\] FAPI-74 is performed on patients diagnosed with malignant tumor, and the pathological condition is determined by comparing with FDG-PET/CT examination of conventional diagnostic imaging.

Timeline

Start
2022-05-09
Primary completion
2026-03-31
Completion
2026-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject FAPI-74 Diagnostic / imaging agent — Other

Indications